Danaher Lifts Full-Year Forecast on Biotech, Life Sciences Gains

Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit momentum in its Biotechnology and Life Sciences segments....

WSJ - 4/21/2026 7:33:00 AM More News for DHR
Stock Analysis for DHR
Related Stocks: